Literature DB >> 34179654

TFA-catalyzed Q-Tube Reactor-Assisted Strategy for the Synthesis of Pyrido[1,2-b][1,2,4]triazine and Pyrido[1',2':2,3][1,2,4]triazino[5,6-b]indole Derivatives.

Hamada Mohamed Ibrahim1,2, Haider Behbehani1.   

Abstract

An efficient high-pressure-assisted trifluoroacetic acid-catalyzed protocol for synthesizing unreported novel pyrido[1,2-b][1,2,4]triazine and pyrido[1',2':2,3][1,2,4]triazino[5,6-b]indole derivatives has been established. This strategy includes the condensation reactions of various 1-amino-2-imino-4-arylpyridine-3-carbonitrile derivatives with indoline-2,3-dione (isatin) derivatives and α-keto acids such as pyruvic acid and phenylglyoxylic acid. This strategy includes utilizing the Q-tube reactor as an efficient and safe tool to conduct these reactions under high-pressure conditions. In addition, trifluoroacetic acid was used to induce this transformation. In this research, conducting the targeted reactions under high pressure using the Q-tube reactor was found to be superb in comparison to that under the traditional refluxing conditions. X-ray single-crystal analysis was utilized in this study to authenticate the structure of the synthesized products.
© 2021 The Authors. Published by American Chemical Society.

Entities:  

Year:  2021        PMID: 34179654      PMCID: PMC8223412          DOI: 10.1021/acsomega.1c01980

Source DB:  PubMed          Journal:  ACS Omega        ISSN: 2470-1343


Introduction

Fused heterocycles containing nitrogen are distinctive building blocks because they are the primary motifs for many natural products and efficiently incorporated in a broad range of heterocyclic compounds that have a significant pharmaceutical effect.[1−3] As such, these ring systems are often considered as important pillars for the design and development of new pharmaceutically active molecules and drugs.[4,5] Pyrido-triazine derivatives and their analogy are among these significant heterocycles, which have shown distinct and diverse biological activities such as anticancer,[6] anti-avian influenza virus (H5N1),[7] antioxidant,[4]triazine-2,6-dione and pyrido[1,2-b][1,2,4]triazepine-2,7-dione derivatives as antioxidant agents. Lett. Org. Chem.. 2017 ">8] antibacterial,[9,10] antifungal,[4]triazine derivatives. J. Braz. Chem. Soc.. 2009 ">11] antimicrobial,[12] and antiviral[13] functions. Moreover, some examples of this class of compounds can act as sirtuin modulators,[14] HIV integrase inhibitors,[15] and antagonists of the histamine H3 receptor.[16] In addition, some pyrido-triazine members showed optical,[4]triazine-7,9-dicarbonitrile. Can. J. Phys.. 2018 ">17,18] fluorescence,[19] and corrosion inhibition properties.[4]triazine-7,9-dicarbonitrile on the corrosion inhibition of steel in HCl media. Pharm. Lett.. 2014 ">20] Also, when indole fused or combined with other heterocyclic compounds, it gave them patentable bioactive characteristics and features such as anticancer,[21−23] antituberculosis,[24] anti-HIV,[25] anticonvulsant,[26] antiviral, anti-inflammatory, antibacterial, and antiparasitic properties.[27,28] It is therefore anticipated that the fusion of the indole moiety with the pyrido-triazine system could serve as a privileged nucleus for many biological evaluation. The synthesis of the fused pyrido-triazine derivatives has drawn the interest of chemists around the world. A variety of methods have been developed to synthesize these systems due to the particular properties and applications mentioned above. As shown in Scheme , the majority of the reported methods[11,17] used 1,6-diamino-4-aryl-2-oxo-1,2-dihydropyridine-3,5-dicarbonitrile as a precursor. Following our efforts to synthesize new heterocyclic compounds through eco-friendly green approaches[29−36] and after thorough literature survey, it was noted that the use of 1-amino-2-imino-4-arylpyridine-3-carbonitrile derivatives as precursors to synthesize pyrido[1′,2′:2,3][1,2,4]triazino[5,6-b]indole and pyrido[1,2-b][1,2,4]triazine derivatives has not been reported to date. The current research involves the reaction of 1-amino-2-imino-4-arylpyridines with indoline-2,3-dione (isatin) and α-keto acids such as pyruvic acid and phenylglyoxylic acid, under high-pressure conditions, using a Q-tube reactor. It is important to note that when the reaction between 1-amino-2-imino-4-arylpyridines and 1,2-dioxo compounds was carried out in AcOH as described in the previous procedures, the desired pyrido-triazine was not produced. The formed product was identified as the corresponding triazolo[1,5-a]pyridine derivatives,[34,36] which were generated via the reaction of 1-amino-2-imino-pyridine with AcOH rather than 1,2-dioxo compounds. Even when EtOH/H3BO4 is used, the reaction does not work, and no products are produced. After much effort, we were able to carry out the desired reactions in the current work by employing the conditions stated in Scheme to produce the corresponding pyrido-triazine derivatives in high yield, as shown later. Herein, the Q-tube was used as a high-pressure tool in this study to carry out the current reactions in a low-cost, safe, and eco-sustainable way. The Q-tube is distinguished from conventional heating and MW irradiation by a number of characteristics and features,[37−40] including enhanced yield and performance, a cleaner product profile resulting in lighter color (fewer byproducts and impurities), energy savings, a shorter reaction time, and higher repeatability and being less costly and safer due to the ease of pressing and sealing; as a result, the explosion that may occur when using a typical sealed tube is avoided. Such intriguing and distinguishing features compelled us to employ the Q-tube technique in our research to investigate the effect of high pressure on the reactions proliferating.
Scheme 1

Previous and Current Work for the Synthesis of Pyrido[1,2-b][1,2,4]triazine Derivatives

Results and Discussion

On the basis of immense pharmaceutical activities of pyrido-triazine and indole-clubbed systems, it is noteworthy to synthesize pyrido[1,2-b][1,2,4]triazine and pyrido[1′,2′:2,3][1,2,4]-triazino[5,6-b]indole derivatives in a safe and green manner. Initially, a series of 1-amino-2-imino-4-arylpyridine-3-carbonitrile 1a–f have been synthesized according to the literature;[33] then, compound 1a was selected to study and estimate the optimal conditions for its reaction with pyruvic acid as an example for α-keto acids. Hence, our investigation began by conducting the reaction between 1-amino-2-imino-pyridine 1a (5 mmol) and pyruvic acid 2a (5 mmol) in different solvents under the ordinary conventional heating conditions to investigate the solvent effect on this reaction profile. Various solvents such as EtOH, acetonitrile, dioxane, dimethyl sulfoxide (DMSO), and toluene (15 mL) have been applied to conduct the abovementioned reaction at refluxing temperature and normal pressure for 12 h. It was found that using these types of solvents did not configure any products. On the other hand, using AcOH or dimethylformamide (DMF) led to the formation of triazolo[1,5-a]pyridine derivatives through its reaction with 1-amino-2-imino-pyridine 1a.[34,36] Interestingly, when the reaction was carried out in EtOH as a solvent containing glacial AcOH (4 equiv) as an additive at reflux for 12 h at 130 °C, the reaction performed well to provide the corresponding 3-methyl-2-oxo-8-phenyl-2H-pyrido[1,2-b][1,2,4]-triazine-9-carbonitrile (3a) in 48% yield (Table , entry 6); the assigned structure for 3a was verified on the basis of the various spectroscopic data, such as MS, HRMS, 1H NMR, and 13C{1H} NMR spectra; furthermore, the X-ray crystallographic technique was used to successfully assign and confirm the structure of an example from this series, 3c, as shown later. Subsequently, we ran the above-modeled reaction under a variety of conditions, in order to boost the reaction yield, as shown in Table ; the best reaction medium was found to be EtOH/AcOH since acids other than AcOH such as PivOH, PTSA, and H3BO4 did not work well, Table , entries 6–9. Surprisingly, it was found that addition of 10 mol % from TFA to the reaction mixture enhances the reaction rate and yield (72%), as shown in Table , entry 10. After that, the AcOH loading has been monitored (Table , entries 10–13) to study its effect on the reaction yield, and it was found that using 3 equiv from AcOH is optimal for the best reaction yield, Table , entry 12. Finally, in order to compare carrying out the model reaction under the traditional refluxing conditions with heating under sealed conditions, the Q-tube reactor was used for this purpose to conduct the reaction under high-pressurized conditions in a safe manner to avoid the accidental explosion that may happen when an ordinary sealed tube was used. Hence, when the model reaction [1-amino-2-imino-pyridine 1a (5 mmol) and pyruvic acid 2a (5 mmol) in EtOH (15 mL), TFA (10 mol %), and AcOH (2 equiv)] was carried out using the Q-tube reactor and by heating in an oil bath at 130 °C for 40 min, it yielded 3a in 94% (Table , entry 15), so using the Q-tube reactor was preferred rather than using traditional reflux for this reaction. It is important to note that the presence of AcOH acid is needed for the completion of the abovementioned reaction (entry 16) because it serves two functions: it acts as a co-solvent to make the reaction mixture soluble and it works with TFA to activate the carbonyl carbons to make them more electrophilic, facilitating the nucleophilic addition of the N–NH2 moiety to the α-carbonyl carbon.
Table 1

Optimization Reaction of 1-Amino-2-imino-pyridine 1a with Pyruvic Acid 2aa

entrysolventadditive (equiv)temp (°C)timeyield (%)
1EtOHnone12012 h0
2CH3CNnone12012 h0
31,4-dioxanenone12012 h0
4DMSOnone14012 h0
5Toluenenone14012 h0
6EtOHAcOH (4)12012 h48
7EtOHPivOH (4)12012 h33
8EtOHPTSA (4)12012 h16
9EtOHH3BO4 (4)13012 h21
10EtOHAcOH (4) + TFA (10 mol %)1305 h72
11EtOHAcOH (5) + TFA (10 mol %)1305 h72
12EtOHAcOH (3) + TFA (10 mol %)1305 h72
13EtOHAcOH (2) + TFA (10 mol %)1305 h64
14bEtOHAcOH (3) + TFA (10 mol %)12040 min89
15bEtOHAcOH (3) + TFA (10 mol %)13040 min94
16bEtOHTFA (10 mol %)13040 mintrace

Reaction conditions: independent mixtures of 1-amino-2-imino-pyridine 1a (5 mmol) and pyruvic acid 2a (5 mmol) in the solvent (15 mL) containing the additive, by refluxing at the indicated temp (°C), for the reported time.

Reaction conditions: independent mixtures of 1-amino-2-imino-pyridine 1a (5 mmol) and pyruvic acid 2a (5 mmol) in the solvent (15 mL) containing the additive were charged in the glass tube of the Q-tube reactor and heated in an oil bath at the indicated temp (°C), for 40 min.

Reaction conditions: independent mixtures of 1-amino-2-imino-pyridine 1a (5 mmol) and pyruvic acid 2a (5 mmol) in the solvent (15 mL) containing the additive, by refluxing at the indicated temp (°C), for the reported time. Reaction conditions: independent mixtures of 1-amino-2-imino-pyridine 1a (5 mmol) and pyruvic acid 2a (5 mmol) in the solvent (15 mL) containing the additive were charged in the glass tube of the Q-tube reactor and heated in an oil bath at the indicated temp (°C), for 40 min. Additional research was conducted to investigate the generalization and limits of the aforementioned TFA-induced di-condensation reaction (Table ) under the optimized conditions achieved from the explorative model reaction (entry 15, Table ). For this purpose, a variety of N-amino-2-iminopyridines 1b–i were synthesized in order to ascertain their condensation reactions with pyruvic acid and phenylglyoxylic acid as examples for α-keto acids under the defined optimum conditions. It is noted that, preferably, the first stage of these reactions proceeds through a condensation reaction between the amino group attached to the pyridine ring (N–NH2) and the keto moiety at the 2 position rather than the 1-keto function of the α-keto acid to enable the non-isolable hydrazone intermediate to endure a further condensation reaction between the hydroxyl moiety of the carboxylic group and the imino group at C2 (C=NH) to afford the desired pyrido[1,2-b][1,2,4]triazine derivatives 3a–o in an excellent yield (Table , Scheme ). As noted during this investigation, the aryl moiety of 1-aminopyridine at C-4 is either phenyl or phenyl substituted with electron-donating/withdrawing substituents that did not have a major effect on the reaction yield; however, in general, the yield in the case of phenylglyoxylic acid is marginally better than in the case of pyruvic acid, as shown in Table . After several trials, we were able to obtain a suitable crystal for the X-ray single-crystallographic measurements in the case of compound 3c to support the abovementioned finding without any doubt (Figure , Table ).
Table 2

Cyclocondensation Reactions between N-Aminopyridines 1a–i and α-keto Acids 2a,b Using the Q-Tubea

Reaction conditions: independent mixtures of 1-amino-2-imino-pyridine 1 (5 mmol) and α-keto acids 2a,b (5 mmol), in EtOH (15 mL), TFA (10 mol %), and AcOH (3 equiv), were charged in the glass tube of the Q-tube reactor and heated in an oil bath at 130 °C for 40 min.

Scheme 2

Plausible Mechanistic Route for the Formation of Pyrido[1,2-b][1,2,4]triazine Derivatives 3a–o

Figure 1

X-ray crystallographic analysis determined for 3c.

Table 3

Some Selected Bond Lengths and Angles for Compound 3c

bondbond length (Å)bondbond angle (deg)
C5–C101.480(9)C3–C4–C6123.4(5)
C5–C61.406(9)C5–C6–C7120.6(6)
C4–C91.451(8)C4–C5–C10123.1(5)
C1–C81.478(9)C2–C1–C8119.5(6)
N1–C31.389(7)C2–N3–C3118.5(5)
N1–C71.368(8)N1–N2–C1116.2(5)
N1–N21.377(7)N1–C3–N3122.9(5)
C2–O11.225(8)N4–C9–C4176.3(6)
Cl3–O21.375(8)C13–O2–C16117.1(5)
X-ray crystallographic analysis determined for 3c. Reaction conditions: independent mixtures of 1-amino-2-imino-pyridine 1 (5 mmol) and α-keto acids 2a,b (5 mmol), in EtOH (15 mL), TFA (10 mol %), and AcOH (3 equiv), were charged in the glass tube of the Q-tube reactor and heated in an oil bath at 130 °C for 40 min. A possible mechanistic route for the formation of pyrido[1,2-b][1,2,4]triazine derivatives 3a–o is depicted in Scheme . The presence of acid makes carbonyl carbons more electrophilic because the proton from acid attaches to the carbonyl oxygen and enfeebles the C=O bond. The nucleophilic addition of the amino group attached to the pyridine ring (N–NH2) to the carbonyl carbon is now easier, resulting in the adduct A, which is converted to the intermediate B during a proton transfer process. The intermediate C was then formed by separating one water molecule through the good leaving group (OH2+) to allow the formation of imine-intermediate D via the loss of a HX molecule. Further nucleophilic addition of the imino group at C-2 (C=NH) to the imide-keto moiety enables the formation of final targeted products 3a–o, through the loss of another water molecule. Continuing the evaluation of the existing methodological technique, the findings of additional research have also shown that this Q-tube-assisted TFA-induced di-condensation reaction was successfully conducted when indoline-2,3-dione (isatin) derivatives (4a–c) were used as cyclic 1,2-dioxo substrates. Hence, reacting 1-amino-2-iminopyridines 1 (5 mmol) with isatin, 5-bromoisatin, and 5-nitroisatin (4a–c) (5 mmol) utilizing the defined optimized conditions [EtOH (15 mL), TFA (10 mol %), AcOH (3 equiv), and the Q-tube reactor at 130 °C for 30 min] provided the corresponding pyrido[1′,2′:2,3][1,2,4]triazino[5,6-b]indole derivatives 5a–r in excellent yields (Table ). It is noted that during this reaction, the 5-bromoisatin and 5-nitroisatin provided better yield than isatin itself. Owing to the crystalline behavior exhibited by this class of compounds, the structure of certain compounds such as 5a, d, g, j, m, and 5o has been verified by the use of single-crystal X-ray crystallography, as shown in Figures –7, Table .
Table 4

Cyclocondensation Reactions between N-Aminopyridine 1 and Isatin Derivatives 4 Using the Q-Tubea

Reaction conditions: independent mixtures of 1-amino-2-imino-pyridine 1 (5 mmol) and isatin derivatives 4a–c (5 mmol), in EtOH (15 mL), TFA (10 mol %), and AcOH (3 equiv), were charged in the glass tube of the Q-tube reactor and heated in an oil bath at 130 °C for 30 min.

Figure 2

X-ray crystallographic analysis determined for 5a.

Figure 7

X-ray crystallographic analysis determined for 5o.

Table 5

Some Selected Bond Lengths and Angles for Compound 5g

bondbond length (Å)bondbond angle (deg)
C3–C151.415(6)C1–C2–C3118.3(5)
C3–C41.415(7)C3–C4–C16105.9(4)
C4–C161.484(6)C5–C6–C7120.8(5)
C6–C71.415(6)C4–C3–C15103.9(4)
N1–C41.303(6)C15–N3–C16104.8(4)
N3–C161.321(6)C16–N4–C17114.7(4)
N1–N21.370(5)C4–N1–N2114.0(4)
N5–C191.147(6)N5–C19–C18175.7(5)
O1–C111.372(6)C11–O1–C12117.6(5)
X-ray crystallographic analysis determined for 5a. X-ray crystallographic analysis determined for 5d. X-ray crystallographic analysis determined for 5g. X-ray crystallographic analysis determined for 5j. X-ray crystallographic analysis determined for 5m. X-ray crystallographic analysis determined for 5o. Reaction conditions: independent mixtures of 1-amino-2-imino-pyridine 1 (5 mmol) and isatin derivatives 4a–c (5 mmol), in EtOH (15 mL), TFA (10 mol %), and AcOH (3 equiv), were charged in the glass tube of the Q-tube reactor and heated in an oil bath at 130 °C for 30 min. A rational mechanistic pathway was postulated for the formation of pyrido[1′,2′:2,3][1,2,4]-triazino[5,6-b]indole derivatives 5a–r (Scheme ), which was preferably initiated by the nucleophilic addition of the amino group attached to the pyridine ring (N–NH2) to the keto moiety of the isatin derivatives pendent at position 3 rather than the imide-keto moiety to enable the formed imine-intermediate B (through losing one water molecule) to undergo further nucleophilic addition of the imino group at C2 (C=NH) to the imide-keto moiety to form the adduct C, which further loses one water molecule to furnish finally the targeted products pyrido[1′,2′:2,3]-[1,2,4]triazino[5,6-b]indole derivatives 5a–r.
Scheme 3

Plausible Mechanistic Route for the Formation of Pyrido[1′,2′:2,3][1,2,4]triazino[5,6-b]indole Derivatives 5a–r

Conclusions

In summary, the abovementioned research led to the development of an effective and straightforward Q-tube-assisted TFA-catalyzed reaction of 1-amino-2-imino-4-arylpyridine-3-carbonitrile derivatives with indoline-2,3-dione (isatin) derivatives and α-keto acids such as pyruvic acid and phenylglyoxylic acid, via utilizing the Q-tube reactor as an efficient and safe tool to conduct these reactions under high-pressurized conditions, to design an unprecedented class from the pyrido[1,2-b][1,2,4]triazine and pyrido[1′,2′:2,3][1,2,4]-triazino[5,6-b]indole derivatives in superb yields. This strategy includes a variety of features and characteristics including quick, safe procedures, easy operation and purification, the ability to apply to a wide range of substrates, and high atom economy. We assume that this protocol may provide a basis for potential applications of these heterocycles, particularly in the field of medicinal and industrial chemistry.

Experimental Section

General

Melting points were recorded on a Griffin melting point apparatus and were uncorrected. IR spectra were recorded using KBr disks and a Jasco FT-IR-6300 spectrophotometer. 1H NMR (600 MHz) and 13C{1H} NMR (150 MHz) spectra were recorded at 25 °C using DMSO-d6 or TFA-d as solvents with tetramethylsilane as an internal standard on a Bruker DPX 600 super-conducting NMR spectrometer. Chemical shifts (δ) were reported in ppm. Low-resolution electron impact mass spectra [MS (EI)] and high-resolution electron impact mass spectra [HRMS (EI)] were characterized using a high-resolution GC–MS (DFS) thermo-spectrometer at 70.1 eV and a magnetic sector mass analyzer. Following the courses of reactions, checking the homogeneity of products was performed using thin-layer chromatography (TLC). The reactions were conducted using a Q Labtech Q-tube (distributed by Sigma-Aldrich), equipped with a stainless-steel adapter attached with a pressure gauge (300 psi), a needle adapter, a borosilicate glass pressure tube (35 mL), a Teflon sleeve, a PTFE-faced silicone septa, and a catch bottle. The X-ray crystallographic data were collected using a Bruker X8 Prospector at room temperature using Cu Kα radiation. The structures were solved using direct methods and expanded using Fourier techniques. The non-hydrogen atoms were refined anisotropically. The structures were solved and refined using the Bruker SHELXTL software package (Structure solution program, SHELXS-97, and refinement program, SHELXL-97).[41] Data were corrected for the absorption effects using the multi-scan method (SADABS). The crystal images were created using Mercury software (version 3.8).[42]

General Procedure for the Preparation of Compounds 3a–o and 5a–r

A mixture of 1-amino-2-imino-pyridine 1a–i (5 mmol) and α-keto acids 2a,b (5 mmol) or isatin derivatives 4a–c (5 mmol), in EtOH (15 mL) containing TFA (10 mol %) and AcOH (3 equiv), was charged in the Q-tube pressure reactor tube (35 mL, borosilicate glass); then, the PTFE-faced silicon septa were placed on the top of the tubes, and the proper cap and pressure adapter were firmly fitted to prevent any leak of vapor pressure. The mixtures were heated in an oil bath at 130 °C for 40 min in the case of α-keto acids and for 30 min in the case of isatin derivatives. All the reactions were monitored by the use of GC/MS and TLC. After completion, the reaction mixtures were cooled and the pressure was released; the formed solids were collected by filtration, washed with water and then EtOH, and left to dry. The formed solids were recrystallized from the proper solvents or a mixture of solvents (see below), to give pyrido[1,2-b]-[1,2,4]triazines 3a–o and pyrido[1′,2′:2,3][1,2,4]-triazino[5,6-b]indoles 5a–r as pure products.

3-Methyl-2-oxo-8-phenyl-2H-pyrido[1,2-b][1,2,4]triazine-9-carbonitrile (3a)

Recrystallized from the EtOH/dioxane mixture (4:1), as a yellowish white crystal, yield: 1.21 g (94%), mp above 300 °C; IR (KBr): ν/cm–1 2234 (C≡N), 1647 (C=O); 1H NMR (600 MHz, DMSO-d6): δ 2.37 (s, 3H, CH3), 7.29 (d, J = 7.2 Hz, 1H, C–H6), 7.64–7.65 (m, 3H, Ar–H), 7.78–7.79 (m, 2H, Ar–H), 8.72 (d, J = 7.2 Hz, 1H, CH-7); 13C{1H} NMR (150 MHz, DMSO-d6): δ 17.66 (CH3), 103.11, 113.82, 114.28, 128.67, 129.09, 131.20, 134.48, 140.35, 151.84, 156.56, 157.90, 159.63; MS (EI): m/z (%) 263 (M+ + 1, 30.01), 262 (M+, 49.21). HRMS (EI): m/z calcd for C15H10N4O (M+), 262.0849; found, 262.0848.

3-Methyl-2-oxo-8-p-tolyl-2H-pyrido[1,2-b][1,2,4]triazine-9-carbonitrile (3b)

Recrystallized from the EtOH/dioxane mixture (4:1), as a yellowish white crystal, yield: 125 g (91%), mp above 300 °C; IR (KBr): ν/cm–1 2235 (C≡N), 1647 (C=O); 1H NMR (600 MHz, DMSO-d6): δ 2.36 (s, 3H, CH3), 2.43 (s, 3H, CH), 7.27 (d, J = 7.2 Hz, 1H, C–H6), 7.45 (d, J = 7.8 Hz, 2H, Ar–H), 7.69 (d, J = 7.8 Hz, 2H, Ar–H), 8.68 (d, J = 7.2 Hz, 1H, CH-7); 13C{1H} NMR (150 MHz, DMSO-d6): δ 17.69, 21.00 (2CH3), 102.61, 113.81, 114.47, 128.71, 129.72, 131.60, 140.24, 141.58, 151.94, 156.53, 157.83, 159.72; MS (EI): m/z (%) 277 (M+ + 1, 28.64), 276 (M+, 54.91). HRMS (EI): m/z calcd for C16H12N4O (M+), 276.1006; found, 276.1006.

8-(4-Methoxyphenyl)-3-methyl-2-oxo-2H-pyrido[1,2-b][1,2,4]triazine-9-carbonitrile (3c)

Recrystallized from the EtOH/dioxane mixture (4:1), as a yellowish white crystal, yield: 1.30 g (89%), mp 286–287 °C; IR (KBr): ν/cm–1 2233 (C≡N), 1659 (C=O); 1H NMR (600 MHz, DMSO-d6): δ 2.35 (s, 3H, CH), 2.87 (s, 3H, OCH), 7.19 (d, J = 8.4 Hz, 2H, Ar–H), 7.28 (d, J = 7.2 Hz, 1H, C–H6), 7.80 (d, J = 8.4 Hz, 2H, Ar–H), 8.66 (d, J = 7.2 Hz, 1H, CH-7); 13C{1H} NMR (150 MHz, DMSO-d6): δ 17.58 (CH3), 55.53 (OCH3), 101.74, 113.61, 114.59, 114.64, 126.30, 130.65, 139.91, 151.98, 155.92, 157.59, 159.63, 161.78; MS (EI): m/z (%) 293 (M+ + 1, 2.85), 292 (M+, 7.32). HRMS (EI): m/z calcd for C16H12N4O2 (M+), 292.0955; found, 292.0953. Crystal Data, moiety formula: C16H12N4O2, M = 292.30, triclinic, a = 7.867(2) Å, b = 10.818(2) Å, c = 16.305(3) Å, V = 1371.8(4) Å3, α = 94.407(7)°, β = 91.928(7)°, γ = 97.087(7)°, space group: P1̅ (#2), Z = 4, Dcalc = 1.415 g·cm–3, no. of reflection measured: 10,889, unique: 4829, 2θmax = 50.1°, R1 = 0.0830 (CCDC 2068868).[43]

8-(4-Chlorophenyl)-3-methyl-2-oxo-2H-pyrido[1,2-b][1,2,4]triazine-9-carbonitrile (3d)

Recrystallized from the EtOH/dioxane mixture (4:1), as a yellowish white crystal, yield: 1.40 g (95%), mp above 300 °C; IR (KBr): ν/cm–1 2230 (C≡N), 1658 (C=O); 1H NMR (600 MHz, TFA-d): δ 2.83 (s, 3H, CH), 7.75 (d, J = 8.4 Hz, 2H, Ar–H), 7.87 (d, J = 8.4 Hz, 2H, Ar–H), 8.02 (d, J = 7.2 Hz, 1H, C–H6), 9.02 (d, J = 7.2 Hz, 1H, CH-7); 13C{1H} NMR (150 MHz, TFA-d): δ 18.43 (CH3), 101.89, 112.04, 123.41, 132.43, 132.57, 132.80, 144.41, 144.69, 150.11, 155.49, 164.16, 164.87; MS (EI): m/z (%) 297 (M+ + 1, 1.69), 296 (M+, 4.53). HRMS (EI): m/z calcd for C15H9ClN4O (M+), 296.0459; found, 296.0460.

8-(4-Bromophenyl)-3-methyl-2-oxo-2H-pyrido[1,2-b][1,2,4]triazine-9-carbonitrile (3e)

Recrystallized from the EtOH/dioxane mixture (4:1), as a yellowish white crystal, yield: 1.60 g (95%), mp above 300 °C; IR (KBr): ν/cm–1 2229 (C≡N), 1656 (C=O); 1H NMR (600 MHz, TFA-d): δ 2.37 (s, 3H, CH), 7.29 (d, J = 7.2 Hz, 1H, C–H6), 7.73 (d, J = 8.4 Hz, 2H, Ar–H), 7.86 (d, J = 8.4 Hz, 2H, Ar–H), 8.74 (d, J = 7.2 Hz, 1H, CH-7); 13C{1H} NMR (150 MHz, TFA-d): δ 17.70 (CH3), 103.30, 113.62, 114.17, 125.09, 130.78, 132.15, 133.66, 140.53, 151.78, 155.48, 158.04, 159.63; MS (EI): m/z (%) 342 (M+ + 2, 54.97), 341 (M+ + 1, 22.63), 340 (M+, 52.04). HRMS (EI): m/z calcd for C15H9BrN4O (M+), 339.9954; found, 339.9963.

3-Methyl-8-(4-nitrophenyl)-2-oxo-2H-pyrido[1,2-b][1,2,4]triazine-9-carbonitrile (3f)

Recrystallized from the EtOH/dioxane mixture (3:1), as a pale white crystal, yield: 1.40 g (92%), mp above 300 °C; IR (KBr): ν/cm–1 2237 (C≡N), 1650 (C=O); 1H NMR (600 MHz, TFA-d): δ 2.39 (s, 3H, CH), 7.36 (d, J = 7.2 Hz, 1H, C–H6), 8.05 (d, J = 8.4 Hz, 2H, Ar–H), 8.47 (d, J = 8.4 Hz, 2H, Ar–H), 8.82 (d, J = 7.2 Hz, 1H, CH-7); 13C{1H} NMR (150 MHz, TFA-d): δ 17.71 (CH3), 104.23, 113.55, 113.83, 124.07, 130.34, 140.56, 140.82, 148.81, 151.61, 154.61, 158.31, 159.56; MS (EI): m/z (%) 308 (M+ + 1, 10.98), 307 (M+, 51.13). HRMS (EI): m/z calcd for C15H9N5O3 (M+), 307.0700; found, 307.0704.

2-Oxo-3,8-diphenyl-2H-pyrido[1,2-b][1,2,4]triazine-9-carbonitrile (3g)

Recrystallized from the EtOH/dioxane mixture (2:1), as a white crystal, yield: 1.55 g (97%), mp above 300 °C; IR (KBr): ν/cm–1 2226 (C≡N), 1656 (C=O); 1H NMR (600 MHz, DMSO-d6): δ 7.37 (d, J = 7.2 Hz, 1H, C–H6), 7.58 (t, J = 7.8 Hz, 2H, Ar–H), 7.63 (t, J = 7.8 Hz, 1H, Ar–H), 7.67–7.68 (m, 3H, Ar–H), 7.82–7.84 (m, 2H, Ar–H), 8.24 (d, J = 7.2 Hz, 2H, Ar–H), 8.52 (d, J = 7.2 Hz, 1H, CH-7); 13C{1H} NMR (150 MHz, DMSO-d6): δ 102.83, 114.19, 114.29, 128.25, 128.72, 129.16, 129.52, 131.32, 131.53, 134.46, 140.69, 151.16, 152.51, 156.61, 158.75; MS (EI): m/z (%) 325 (M+ + 1, 5.96), 324 (M+, 8.05). HRMS (EI): m/z calcd for C20H12N4O (M+) 324.1006; found, 324.1007.

2-Oxo-3-phenyl-8-p-tolyl-2H-pyrido[1,2-b][1,2,4]triazine-9-carbonitrile (3h)

Recrystallized from the EtOH/dioxane mixture (2:1), as a white crystal, yield: 1.55 g (92%), mp above 300 °C; IR (KBr): ν/cm–1 2225 (C≡N), 1656 (C=O); 1H NMR (600 MHz, DMSO-d6): δ 3.45 (s, 3H, CH), 7.35 (d, J = 7.2 Hz, 1H, C–H6), 7.48 (d, J = 7.8 Hz, 2H, Ar–H), 7.57 (t, J = 7.8 Hz, 2H, Ar–H), 7.62 (t, J = 7.8 Hz, 1H, Ar–H), 7.74 (d, J = 7.8 Hz, 2H, Ar–H), 8.23 (d, J = 7.8 Hz, 2H, Ar–H), 8.81 (d, J = 7.2 Hz, 1H, CH-7); 13C{1H} NMR (150 MHz, DMSO-d6): δ 21.00, 102.29, 114.12, 114.45, 128.25, 129.73, 129.52, 129.74, 131.50, 131.56, 140.54, 141.68, 151.23, 152.42, 156.52, 158.78; MS (EI): m/z (%) 339 (M+ + 1, 5.02), 338 (M+, 10.03). HRMS (EI): m/z calcd for C21H14N4O (M+), 338.1162; found, 338.1163.

8-(4-Methoxyphenyl)-2-oxo-3-phenyl-2H-pyrido[1,2-b][1,2,4]triazine-9-carbonitrile (3i)

Recrystallized from the EtOH/dioxane mixture (2:1), as a white crystal, yield: 1.65 g (93%), mp above 300 °C; IR (KBr): ν/cm–1 2229 (C≡N), 1648 (C=O); 1H NMR (600 MHz, DMSO-d6): δ 3.90 (s, 3H, OCH), 7.23 (d, J = 7.8 Hz, 2H, Ar–H), 7.36 (d, J = 7.2 Hz, 1H, C–H6), 7.57 (t, J = 7.8 Hz, 2H, Ar–H), 7.62 (t, J = 7.8 Hz, 1H, Ar–H), 7.85 (d, J = 7.8 Hz, 2H, Ar–H), 8.22 (d, J = 7.8 Hz, 2H, Ar–H), 8.78 (d, J = 7.2 Hz, 1H, CH-7); 13C{1H} NMR (150 MHz, DMSO-d6): δ 55.60, 101.42, 114.02, 114.69, 114.71, 126.30, 128.24, 129.50, 130.76, 131.45, 131.59, 140.29, 151.34, 152.29, 155.98, 158.79, 161.91; MS (EI): m/z (%) 355 (M+ + 1, 4.83), 354 (M+, 6.12). HRMS (EI): m/z calcd for C21H14N4O2 (M+), 354.1111; found, 354.1111.

8-(4-Chlorophenyl)-2-oxo-3-phenyl-2H-pyrido[1,2-b][1,2,4]triazine-9-carbonitrile (3j)

Recrystallized from the EtOH/dioxane mixture (2:1), as a white crystal, yield: 1.72 g (97%), mp above 300 °C; IR (KBr): ν/cm–1 2232 (C≡N), 1649 (C=O); 1H NMR (600 MHz, DMSO-d6): δ 7.38 (d, J = 7.2 Hz, 1H, C–H6), 7.58 (t, J = 7.8 Hz, 2H, Ar–H), 7.63 (t, J = 7.8 Hz, 1H, Ar–H), 7.76 (d, J = 8.4 Hz, 2H, Ar–H), 7.85 (d, J = 8.4 Hz, 2H, Ar–H), 8.23 (d, J = 7.8 Hz, 2H, Ar–H), 8.87 (d, J = 7.2 Hz, 1H, CH-7); 13C{1H} NMR (150 MHz, DMSO-d6): δ 103.08, 114.00, 114.15, 128.26, 129.24, 129.52, 130.65, 131.50, 131.58, 133.27, 140.80, 151.05, 151.12, 152.58, 155.49, 158.73; MS (EI): m/z (%) 359 (M+ + 1, 19.98), 358 (M+, 46.13). HRMS (EI): m/z calcd for C20H11ClN4O (M+), 358.0616; found, 358.0614.

8-(4-Bromophenyl)-2-oxo-3-phenyl-2H-pyrido[1,2-b][1,2,4]triazine-9-carbonitrile (3k)

Recrystallized from the EtOH/dioxane mixture (2:1), as a white crystal, yield: 1.95 g (98%), mp above 300 °C; IR (KBr): ν/cm–1 2231 (C≡N), 1648 (C=O); 1H NMR (600 MHz, DMSO-d6): δ 7.37 (d, J = 7.2 Hz, 1H, C–H6), 7.58 (t, J = 7.8 Hz, 2H, Ar–H), 7.63 (t, J = 7.8 Hz, 1H, Ar–H), 7.78 (d, J = 8.4 Hz, 2H, Ar–H), 7.89 (d, J = 8.4 Hz, 2H, Ar–H), 8.23 (d, J = 7.8 Hz, 2H, Ar–H), 8.87 (d, J = 7.2 Hz, 1H, CH-7); 13C{1H} NMR (150 MHz, DMSO-d6): δ 102.99, 113.95, 114.16, 125.19, 128.27, 129.53, 130.80, 131.48, 131.57, 132.19, 133.61, 140.83, 151.07, 152.58, 155.49, 158.71; MS (EI): m/z (%) 404 (M+ + 2, 8.01), 403 (M+ + 1, 3.49), 402 (M+, 6.72). HRMS (EI): m/z calcd for C20H11BrN4O (M+), 402.0111; found, 402.0115.

8-4-(Fluorophenyl)-2-oxo-3-phenyl-2H-pyrido[1,2-b][1,2,4]triazine-9-carbonitrileitrile (3l)

Recrystallized from the EtOH/dioxane mixture (2:1), as a white crystal, yield: 1.60 g (95%), mp above 300 °C; IR (KBr): ν/cm–1 2230 (C≡N), 1647 (C=O); 1H NMR (600 MHz, DMSO-d6): δ 7.31 (d, J = 7.2 Hz, 1H, C–H6), 7.47–7.50 (m, 2H, Ar–H), 7.57 (t, J = 7.8 Hz, 2H, Ar–H), 7.63 (t, J = 7.8 Hz, 1H, Ar–H), 7.88–7.91 (m, 2H, Ar–H), 8.27 (d, J = 7.8 Hz, 2H, Ar–H), 8.74 (d, J = 7.2 Hz, 1H, CH-7); 13C{1H} NMR (150 MHz, DMSO-d6): δ 103.76, 113.45, 113.55, 115.64, 115.78, 124.04, 127.69, 129.03, 130.75, 130.81, 130.95, 139.88, 149.06, 150.60, 152.24, 155.21; MS (EI): m/z (%) 343 (M+ + 1, 8.91), 342 (M+, 21.19). HRMS (EI): m/z calcd for C20H11FN4O (M+), 342.0911; found, 342.0913.

8-(4-Nitrophenyl)-2-oxo-3-phenyl-2H-pyrido[1,2-b][1,2,4]triazine-9-carbonitrile (3m)

Recrystallized from the EtOH/dioxane mixture (2:1), as a canary-yellow crystal, yield: 1.70 g (94%), mp above 300 °C; IR (KBr): ν/cm–1 2235 (C≡N), 1650 (C=O); 1H NMR (600 MHz, DMSO-d6): δ 7.39 (d, J = 7.2 Hz, 1H, C–H6), 7.58 (t, J = 7.8 Hz, 2H, Ar–H), 7.64 (t, J = 7.8 Hz, 1H, Ar–H), 8.08 (d, J = 8.4 Hz, 2H, Ar–H), 8.27 (d, J = 7.8 Hz, 2H, Ar–H), 8.48 (d, J = 8.4 Hz, 2H, Ar–H), 8.88 (d, J = 7.2 Hz, 1H, CH-7); 13C{1H} NMR (150 MHz, DMSO-d6): δ 103.88, 113.40, 113.56, 123.79, 127.99, 129.29, 130.03, 131.22, 131.35, 140.37, 140.73, 148.73, 150.62, 152.59, 154.42, 158.30; MS (EI): m/z (%) 370 (M+ + 1, 2.01), 369 (M+, 5.42). HRMS (EI): m/z calcd for C20H11N5O3 (M+), 369.0856; found, 369.0857.

8-(4-Aminophenyl)-2-oxo-3-phenyl-2H-pyrido[1,2-b][1,2,4]triazine-9-carbonitrile (3n)

Recrystallized from the EtOH/dioxane mixture (2:1), as an orange crystal, yield: 1.50 g (90%), mp above 300 °C; IR (KBr): ν/cm–1 3479, 3360 (NH2), 2214 (C≡N), 1650 (C=O); 1H NMR (600 MHz, DMSO-d6): δ 6.22 (s, 2H, NH), 6.75 (d, J = 8.4 Hz, 2H, Ar–H), 7.29 (d, J = 7.2 Hz, 1H, C–H6), 7.55 (t, J = 7.8 Hz, 2H, Ar–H), 7.60 (t, J = 7.8 Hz, 1H, Ar–H), 7.68 (d, J = 8.4 Hz, 2H, Ar–H), 8.20 (d, J = 7.8 Hz, 2H, Ar–H), 8.61 (d, J = 7.2 Hz, 1H, CH-7); 13C{1H} NMR (150 MHz, DMSO-d6): δ 97.94, 113.43, 113.52, 115.53, 119.78, 128.17, 129.43, 130.88, 131.24, 131.75, 139.34, 151.72, 151.78, 152.87, 155.82, 158.88; MS (EI): m/z (%) 340 (M+ + 1, 1.02), 339 (M+, 3.12). HRMS (EI): m/z calcd for C20H13N5O (M+), 339.1115; found, 339.1115.

8-Methyl-2-oxo-3-phenyl-2H-pyrido[1,2-b][1,2,4]triazine-9-carbonitrile (3o)

Recrystallized from the EtOH/dioxane mixture (2:1), as a pale-yellow crystal, yield: 1.15 g (87%), mp above 300 °C; IR (KBr): ν/cm–1 2227 (C≡N), 1651 (C=O); 1H NMR (600 MHz, DMSO-d6): δ 2.65 (s, 3H, CH), 7.20 (d, J = 7.2 Hz, 1H, C–H6), 7.56 (t, J = 7.8 Hz, 2H, Ar–H), 7.61 (t, J = 7.8 Hz, 1H, Ar–H), 8.18 (d, J = 7.8 Hz, 2H, Ar–H), 8.70 (d, J = 7.2 Hz, 1H, CH-7); 13C{1H} NMR (150 MHz, DMSO-d6): δ 20.99 (CH3), 104.56, 113.66, 115.37, 128.19, 129.44, 131.36, 131.59, 139.97, 150.45, 152.46, 158.32, 158.75; MS (EI): m/z (%) 263 (M+ + 1, 3.85), 262 (M+, 13.02). HRMS (EI): m/z calcd for C15H10N4O (M+), 262.0849; found, 262.0847.

9-Phenylpyrido[1′,2′:2,3][1,2,4]triazino[5,6-b]indole-10-carbonitrile (5a)

Recrystallized from the EtOH/DMF mixture (1:4), as orange crystals, yield: 1.55 g (96%), mp above 300 °C; IR (KBr): ν/cm–1 2227 (C≡N), 1640, 1603 (C=N); 1H NMR (600 MHz, TFA-d): δ 7.66–7.72 (m, 4H, Ar–H), 7.79 (d, J = 7.8 Hz, 1H, CH-7), 7.87 (d, J = 7.2 Hz, 2H, Ar–H), 8.03 (t, J = 7.2 Hz, 1H, Ar–H), 8.08 (d, J = 7.2 Hz, 1H, Ar–H), 8.51 (d, J = 7.8 Hz, 1H, CH-8), 9.33 (d, J = 7.2 Hz, 1H, Ar–H); 13C{1H} NMR (150 MHz, TFA-d): δ 108.03, 112.35, 115.52, 116.25, 122.75, 126.66, 127.59, 129.98, 130.99, 133.91, 134.49, 139.11, 142.69, 145.57, 146.60, 147.34, 148.99, 162.24; MS (EI): m/z (%) 322 (M+ + 1, 23.05), 321 (M+, 100.00). HRMS (EI): m/z calcd for C20H11N5 (M+), 321.1009; found, 321.1008. Crystal data, moiety formula: C20H11N5, M = 321.34, sum formula: C40H22N10, M = 642.68, triclinic, a = 7.0765(5) Å, b = 14.1844(9) Å, c = 15.9271(10) Å, V = 1515.44(17) Å3, α = 76.326(4)°, β = 77.458(5)°, γ = 88.903(5)°, space group: P1̅, Z = 2, Dcalc = 1.408 g·cm–3, no. of reflection measured: 21,148, unique: 5231, θmax = 66.69°, R1 = 0.049 (CCDC 2070152).[43]

3-Bromo-9-phenylpyrido[1′,2′:2,3][1,2,4]triazino[5,6-b]indole-10-carbonitrile (5b)

Recrystallized from DMF, as reddish pink crystals, yield: 1.95 g (98%), mp above 300 °C; IR (KBr): ν/cm–1 2228 (C≡N), 1640, 1600 (C=N); 1H NMR (600 MHz, TFA-d): δ 7.72–7.78 (m, 4H, 3Ar–H and CH-7), 7.93 (d, J = 7.8 Hz, 2H, Ar–H), 8.16–8.19 (m, 2H, Ar–H), 8.67 (d, J = 1.8 Hz, 1H, Ar–H), 9.39 (d, J = 7.2 Hz, 1H, CH-8); 13C{1H} NMR (150 MHz, TFA-d): δ 109.35, 113.47, 118.09, 119.08, 122.14, 124.34, 130.49, 131.32, 132.30, 135.08, 135.90, 143.15, 144.04, 145.88, 146.57, 148.52, 150.36, 163.76; MS (EI): m/z (%) 401 (M+ + 2, 100.00), 400 (M+ + 1, 49.23), 399 (M+, 96.14). HRMS (EI): m/z calcd for C20H10BrN5 (M+), 399.0114; found, 399.0113.

3-Nitro-9-phenylpyrido[1′,2′:2,3][1,2,4]triazino[5,6-b]indole-10-carbonitrile (5c)

Recrystallized from DMF, as reddish brown crystals, yield: 1.70 g (93%), mp above 300 °C; IR (KBr): ν/cm–1 2233 (C≡N), 1644, 1603 (C=N); 1H NMR (600 MHz, TFA-d): δ 7.72 (t, J = 7.8 Hz, 2H, Ar–H), 7.77 (t, J = 7.8 Hz, 1H, Ar–H), 7.93 (d, J = 7.8 Hz, 2H, Ar–H), 8.02 (d, J = 9.0 Hz, 1H, Ar–H), 8.25 (d, J = 7.2 Hz, 1H, CH-7), 8.92 (dd, J = 9.0, 2.4 Hz, 1H, Ar–H), 9.43 (d, J = 1.8 Hz, 1H, Ar–H), 9.46 (d, J = 7.2 Hz, 1H, CH-8); 13C{1H} NMR (150 MHz, TFA-d): δ 109.48, 113.00, 118.07, 123.74, 125.05, 131.18, 132.11, 134.35, 134.66, 135.89, 144.00, 146.11, 147.49, 150.00, 150.48, 151.56, 164.14; MS (EI): m/z (%) 367 (M+ + 1, 25.68), 366 (M+, 100.00). HRMS (EI): m/z calcd for C20H10N6O2 (M+), 366.0860; found, 366.0862.

9-(p-Tolyl)pyrido[1′,2′:2,3][1,2,4]triazino[5,6-b]indole-10-carbonitrile (5d)

Recrystallized from the EtOH/DMF mixture (1:4), as deep-orange crystals, yield: 1.55 g (94%), mp 295–296 °C; IR (KBr): ν/cm–1 2235 (C≡N), 1641, 1602 (C=N); 1H NMR (600 MHz, DMSO-d6): δ 2.46 (s, 3H, CH), 7.40 (t, J = 7.2 Hz, 1H, Ar–H), 7.49 (d, J = 7.8 Hz, 2H, Ar–H), 7.56 (d, J = 7.2 Hz, 1H, CH-7), 7.76 (d, J = 7.2 Hz, 1H, Ar–H), 7.79–8.82 (m, 3H, Ar–H), 8.28 (d, J = 7.2 Hz, 1H, Ar–H), 9.22 (d, J = 7.2 Hz, 1H, CH-8); 13C{1H} NMR (150 MHz, DMSO-d6): δ 21.01 (CH), 105.04, 114.65, 114.92, 118.72, 119.50, 121.88, 123.69, 128.95, 129.80, 131.76, 134.57, 141.10, 141.46, 146.00, 147.63, 150.54, 154.44, 161.46; MS (EI): m/z (%) 336 (M+ + 1, 34.08), 335 (M+, 100.00). HRMS (EI): m/z calcd for C21H13N5 (M+), 335.1165; found, 335.1167. Crystal data, moiety formula: C21H13N5, M = 335.36, orthorhombic, a = 18.444(2) Å, b = 12.6807(12) Å, c = 6.8046(7) Å, V = 1591.5(3) Å3, α = β = γ = 90.0, space group: Pna21, Z = 4, Dcalc = 1.400 g·cm–3, no. of reflection measured: 13,184, unique: 2379, θmax = 66.62°, R1 = 0.0687 (CCDC 2070156).[43]

3-Bromo-9-(p-tolyl)pyrido[1′,2′:2,3][1,2,4]triazino[5,6-b]indole-10-carbonitrile (5e)

Recrystallized from the EtOH/DMF mixture (1:4), as deep-orange crystals, yield: 1.95 g (95%), mp above 300 °C; IR (KBr): ν/cm–1 2227 (C≡N), 1640, 1599 (C=N); 1H NMR (600 MHz, TFA-d): δ 2.50 (s, 3H, CH), 7.53 (d, J = 7.8 Hz, 2H, Ar–H), 7.70 (d, J = 9.0 Hz, 1H, Ar–H), 7.82 (d, J = 7.8 Hz, 2H, Ar–H), 8.11–8.15 (m, 2H, CH-7 and 1 Ar–H), 8.63 (d, J = 1.8 Hz, 1H, Ar–H), 9.30 (d, J = 7.2 Hz, 1H, CH-8); 13C{1H} NMR (150 MHz, TFA-d): δ 22.28 (CH), 108.37, 113.63, 117.94, 119.02, 122.00, 124.14, 130.35, 131.39, 132.02, 132.99, 142.97, 143.66, 145.66, 146.44, 148.42, 148.46, 150.40, 163.56; MS (EI): m/z (%) 415 (M+ + 2, 100.00), 414 (M+ + 1, 40.11), 413 (M+, 99.18). HRMS (EI): m/z calcd for C21H12N5Br (M+), 413.0271; found, 413.0277.

3-Nitro-9-(p-tolyl)pyrido[1′,2′:2,3][1,2,4]triazino[5,6-b]indole-10-carbonitrile (5f)

Recrystallized from the EtOH/DMF mixture (1:4), as deep-orange crystals, yield: 1.75 g (92%), mp above 300 °C; IR (KBr): ν/cm–1 2228 (C≡N), 1642, 1602 (C=N); 1H NMR (600 MHz, TFA-d): δ 2.52 (s, 3H, CH), 7.56 (d, J = 7.8 Hz, 2H, Ar–H), 7.88 (d, J = 7.8 Hz, 2H, Ar–H), 8.03 (d, J = 9.0 Hz, 1H, Ar–H), 8.25 (d, J = 7.8 Hz, 1H, CH-7), 8.91 (dd, J = 9.0, 1.8 Hz, 1H, Ar–H), 9.41–9.43 (m, 2H, CH-8 and 1Ar–H); 13C{1H} NMR (150 MHz, TFA-d): δ 22.46 (CH), 108.87, 113.61, 117.80, 118.41, 123.94, 125.23, 131.67, 132.04, 133.17, 134.50, 144.03, 146.23, 147.69, 148.76, 150.31, 150.88, 151.884, 164.24; MS (EI): m/z (%) 381 (M+ + 1, 24.36), 380 (M+, 100.00). HRMS (EI): m/z calcd for C21H12N6O2 (M+), 380.1016; found, 380.1020.

9-(4-Methoxyphenyl)pyrido[1′,2′:2,3][1,2,4]triazino[5,6-b]indole-10-carbonitrile (5g)

Recrystallized from the EtOH/DMF mixture (1:4), as deep-orange crystals, yield: 1.65 g (95%), mp 292–293 °C; IR (KBr): ν/cm–1 2226 (C≡N), 1641, 1607 (C=N); 1H NMR (600 MHz, DMSO-d6): δ 3.93 (s, 3H, OCH), 7.23 (d, J = 8.4 Hz, 2H, Ar–H), 7.40 (t, J = 7.2 Hz, 1H, Ar–H), 7.52 (d, J = 7.2 Hz, 1H, CH-7), 7.76 (d, J = 7.2 Hz, 1H, Ar–H), 7.82 (t, J = 7.2 Hz, 1H, Ar–H), 7.90 (d, J = 8.4 Hz, 2H, Ar–H), 8.26 (d, J = 7.2 Hz, 1H, Ar–H), 9.09 (d, J = 7.2 Hz, 1H, CH-8); 13C{1H} NMR (150 MHz, DMSO-d6): δ 55.16 (OCH), 104.07, 113.99, 114.22, 114.36, 118.31, 119.01, 121.28, 122.98, 126.28, 130.22, 133.91, 139.95, 145.51, 147.29, 149.92, 153.54, 161.21, 161.47; MS (EI): m/z (%) 352 (M+ + 1, 31.14), 351 (M+, 100.00). HRMS (EI): m/z calcd for C21H13N5O (M+), 351.1115; found, 351.1115. Crystal data, moiety formula: C21H13N5O, M = 351.36, monoclinic, a = 16.3529(14) Å, b = 14.2319(13) Å, c = 7.2576(8) Å, V = 1675.6(3) Å3, α = γ = 90.0°, β = 97.256(8)°, space group: P121/c1, Z = 4, Dcalc = 1.393 g·cm–3, no. of reflection measured: 14,541, unique: 2896, θmax = 66.77°, R1 = 0.0712 (CCDC 2070154).[43]

3-Bromo-9-(4-methoxyphenyl)pyrido[1′,2′:2,3][1,2,4]triazino[5,6-b]indole-10-carbonitrile (5h)

Recrystallized from the EtOH/DMF mixture (1:4), as deep-orange crystals, yield: 2.00 g (97%), mp above 300 °C; IR (KBr): ν/cm–1 2227 (C≡N), 1642, 1602 (C=N); 1H NMR (600 MHz, TFA-d): δ 4.25 (s, 3H, OCH), 7.51 (d, J = 8.4 Hz, 2H, Ar–H), 7.93 (d, J = 7.2 Hz, 1H, CH-7), 8.21 (d, J = 7.8 Hz, 2H, Ar–H), 8.34 (d, J = 8.4 Hz, 2H, Ar–H), 8.84 (s, 1H, Ar–H), 9.51 (d, J = 7.2 Hz, 1H, CH-8); 13C{1H} NMR (150 MHz, TFA-d): δ 57.78 (OCH), 107.74, 114.23, 118.24, 119.32, 122.06, 124.09, 128.02, 130.52, 134.10, 143.03, 143.77, 145.78, 146.67, 148.73, 150.75, 162.56, 166.48; MS (EI): m/z (%) 431 (M+ + 2, 100.00), 430 (M+ + 1, 32.98), 429 (M+, 99.10). HRMS (EI): m/z calcd for C21H12BrN5O (M+), 429.0220; found, 429.0223.

9-(4-Methoxyphenyl)-3-nitropyrido[1′,2′:2,3][1,2,4]triazino[5,6-b]indole-10-carbonitrile (5i)

Recrystallized from the EtOH/DMF mixture (1:4), as deep-orange crystals, yield: 1.85 g (94%), mp above 300 °C; IR (KBr): ν/cm–1 2226 (C≡N), 1643, 1598 (C=N); 1H NMR (600 MHz, TFA-d): δ 4.03 (s, 3H, OCH), 7.30 (d, J = 9.0 Hz, 2H, Ar–H), 8.00–8.02 (m, 3H, Ar–H), 8.22 (d, J = 7.2 Hz, 1H, CH-7), 8.91 (dd, J = 9.0, 2.4 Hz, 1H, Ar–H), 9.36 (d, J = 7.2 Hz, 1H, CH-8), 9.41 (d, J = 1.8 Hz, 1H, Ar–H); 13C{1H} NMR (150 MHz, TFA-d): δ 57.39 (OCH), 107.59, 113.56, 117.49, 118.00, 118.18, 123.66, 124.61, 127.37, 133.91, 134.25, 143.51, 145.86, 147.46, 150.11, 150.81, 151.56, 162.82, 166.55; MS (EI): m/z (%) 397 (M+ + 1, 29.13), 396 (M+, 100.00). HRMS (EI): m/z calcd for C21H12N6O3 (M+), 396.0965; found, 396.0961.

9-(4-Chlorophenyl)pyrido[1′,2′:2,3][1,2,4]triazino[5,6-b]indole-10-carbonitrile (5j)

Recrystallized from the EtOH/DMF mixture (1:4), as deep-orange crystals, yield: 1.70 g (97%), mp above 300 °C; IR (KBr): ν/cm–1 2228 (C≡N), 1640, 1597 (C=N); 1H NMR (600 MHz, DMSO-d6): δ 7.41 (t, J = 7.2 Hz, 1H, Ar–H), 7.58 (d, J = 7.2 Hz, 1H, CH-7), 7.76–7.78 (m, 3H, Ar–H), 7.83 (t, J = 7.2 Hz, 1H, Ar–H), 7.91 (d, J = 8.4 Hz, 2H, Ar–H), 8.29 (d, J = 7.2 Hz, 1H, Ar–H), 9.28 (d, J = 7.2 Hz, 1H, CH-8); 13C{1H} NMR (150 MHz, DMSO-d6): δ 105.69, 113.88, 114.01, 118.35, 119.20, 121.56, 123.21, 128.80, 130.27, 133.21, 134.20, 135.82, 140.63, 145.33, 147.56, 149.90, 152.97, 161.26; MS (EI): m/z (%) 357 (M+ + 2, 28.05), 356 (M+ + 1, 24.89), 355 (M+, 100.00). HRMS (EI): m/z calcd for C20H10ClN5 (M+), 355.0619; found, 355.0618. Crystal data, moiety formula: C20H10ClN5, M = 355.78, monoclinic, a = 16.5160(13) Å, b = 14.1547(11) Å, c = 7.1025(7) Å, V = 1660.1(2) Å3, α = γ = 90.0°, β = 91.122(6)°, space group: P121/c1, Z = 4, Dcalc = 1.423 g·cm–3, no. of reflection measured: 14,441, unique: 2891, θmax = 66.61°, R1 = 0.0628 (CCDC 2070153).[43]

3-Bromo-9-(4-chlorophenyl)pyrido[1′,2′:2,3][1,2,4]triazino[5,6-b]indole-10-carbonitrile (5k)

Recrystallized from the EtOH/DMF mixture (1:4), as deep-orange crystals, yield: 2.15 g (99%), mp above 300 °C; IR (KBr): ν/cm–1 2227 (C≡N), 1640, 1595 (C=N); 1H NMR (600 MHz, TFA-d): δ 7.49 (d, J = 7.2 Hz, 2H, Ar–H), 7.54 (d, J = 7.2 Hz, 1H, CH-7), 7.69 (d, J = 7.2 Hz, 2H, Ar–H), 7.95 (d, J = 7.8 Hz, 2H, Ar–H), 8.46 (s, 1H, Ar–H), 9.22 (d, J = 7.2 Hz, 1H, CH-8); 13C{1H} NMR (150 MHz, TFA-d): δ 110.09, 114.12, 118.85, 119.74, 122.64, 124.66, 131.11, 133.28, 133.35, 134.15, 143.66, 143.73, 144.94, 146.50, 147.24, 149.09, 150.92, 162.66; MS (EI): m/z (%) 435 (M+ + 2, 100.00), 434 (M+ + 1, 34.02), 433 (M+, 77.10). HRMS (EI): m/z calcd for C20H9BrClN5 (M+), 432.9724; found, 432.9722.

9-(4-Chlorophenyl)-3-nitropyrido[1′,2′:2,3][1,2,4]triazino[5,6-b]indole-10-carbonitrile (5l)

Recrystallized from the EtOH/DMF mixture (1:4), as deep-orange crystals, yield: 1.90 g (95%), mp above 300 °C; IR (KBr): ν/cm–1 2230 (C≡N), 1643, 1593 (C=N); 1H NMR (600 MHz, TFA-d): δ 7.65 (d, J = 8.4 Hz, 2H, Ar–H), 7.85 (d, J = 8.4 Hz, 2H, Ar–H), 7.99 (d, J = 9.0 Hz, 1H, Ar–H), 8.19 (d, J = 7.2 Hz, 1H, CH-7), 8.87 (dd, J = 9.0, 1.8 Hz, 1H, Ar–H), 9.37 (d, J = 2.4 Hz, 1H, Ar–H), 9.43 (d, J = 7.2 Hz, 1H, CH-8); 13C{1H} NMR (150 MHz, TFA-d): δ 110.09, 113.47, 118.61, 124.29, 125.29, 133.05, 133.07, 133.53, 134.90, 143.93, 144.78, 146.70, 148.02, 150.53, 151.01, 152.11, 163.12; MS (EI): m/z (%) 401 (M+ + 1, 24.05), 400 (M+, 100.00). HRMS (EI): m/z calcd for C20H9ClNO2 (M+), 400.0470; found, 400.0469.

9-(4-Bromophenyl)pyrido[1′,2′:2,3][1,2,4]triazino[5,6-b]indole-10-carbonitrile (5m)

Recrystallized from the EtOH/DMF mixture (1:4), as deep-orange crystals, yield: 1.95 g (98%), mp above 300 °C; IR (KBr): ν/cm–1 2227 (C≡N), 1639, 1590 (C=N); 1H NMR (600 MHz, DMSO-d6): δ 7.42 (t, J = 7.2 Hz, 1H, Ar–H), 7.58 (d, J = 7.2 Hz, 1H, CH-7), 7.78 (d, J = 7.2 Hz, 1H, Ar–H), 7.82–7.84 (m, 3H, Ar–H), 7.91 (d, J = 8.4 Hz, 2H, Ar–H), 8.30 (d, J = 7.2 Hz, 1H, Ar–H), 9.28 (d, J = 7.2 Hz, 1H, CH-8); 13C{1H} NMR (150 MHz, DMSO-d6): δ 105.75, 114.45, 114.64, 118.69, 119.56, 122.00, 123.76, 125.06, 131.03, 132.24, 133.82, 134.68, 141.38, 145.82, 147.75, 150.43, 153.39, 161.44; MS (EI): m/z (%) 401 (M+ + 2, 100.00), 400 (M+ + 1, 37.04), 399 (M+, 98.23). HRMS (EI): m/z calcd for C20H10BrN5 (M+) 399.0114; found, 399.0115. Crystal data, moiety formula: C20H10BrN5, M = 400.24, monoclinic, a = 16.8422(8) Å, b = 14.1742(8) Å, c = 7.0948(4) Å, V = 1693.45(16) Å3, α = γ = 90.0°, β = 90.995(4)°, space group: P121/c1, Z = 4, Dcalc = 1.570 g·cm–3, no. of reflection measured: 16,759, unique: 2893, θmax = 66.75°, R1 = 0.0551 (CCDC 2070155).[43]

9-(4-Nitrophenyl)pyrido[1′,2′:2,3][1,2,4]triazino[5,6-b]indole-10-carbonitrile (5n)

Recrystallized from the EtOH/DMF mixture (1:4), as deep-orange crystals, yield: 1.65 g (92%), mp above 300 °C; IR (KBr): ν/cm–1 2230 (C≡N), 1641, 1598 (C=N); 1H NMR (600 MHz, TFA-d): δ 7.76 (t, J = 7.8 Hz, 1H, Ar–H), 7.84 (d, J = 7.8 Hz, 1H, Ar–H), 8.06–8.13 (m, 4H, CH-7 and 3 Ar–H), 8.55–8.58 (m, 3H, Ar–H), 9.48 (d, J = 7.2 Hz, 1H, CH-8); 13C{1H} NMR (150 MHz, TFA-d): δ 105.74, 112.71, 116.75, 117.25, 123.23, 127.07, 127.92, 128.84, 132.54, 140.48, 141.60, 144.72, 146.93, 147.76, 148.25, 149.80, 152.15, 160.03; MS (EI): m/z (%) 367 (M+ + 1, 23.41), 366 (M+, 100.00). HRMS (EI): m/z calcd for C20H10N6O2 (M+), 366.0860; found, 366.0862.

9-(4-Aminophenyl)pyrido[1′,2′:2,3][1,2,4]triazino[5,6-b]indole-10-carbonitrile (5o)

Recrystallized from the EtOH/DMF mixture (1:4), as deep-orange crystals, yield: 1.55 g (94%), mp above 300 °C; IR (KBr): ν/cm–1 3431, 3302 (NH2), 2228 (C≡N), 1637, 1589 (C=N); 1H NMR (600 MHz, DMSO-d6): δ 6.18 (s, 2H, NH), 6.77 (d, J = 8.4 Hz, 2H, Ar–H), 7.34 (t, J = 7.2 Hz, 1H, Ar–H), 7.49 (d, J = 7.2 Hz, 1H, CH-7), 7.69–7.73 (m, 3H, Ar–H), 7.77 (t, J = 7.2 Hz, 1H, Ar–H), 8.21 (d, J = 7.2 Hz, 1H, Ar–H), 9.01 (d, J = 7.2 Hz, 1H, CH-8); 13C{1H} NMR (150 MHz, DMSO-d6): δ 101.42, 114.12, 114.63, 116.37, 119.32, 119.78, 120.61, 122.05, 123.92, 131.42, 134.73, 140.40, 147.12, 147.70, 151.31, 153.09, 154.52, 161.96; MS (EI): m/z (%) 337 (M+ + 1, 28.07), 336 (M+, 100.00). HRMS (EI): m/z calcd for C20H12N6 (M+), 336.1118; found, 336.1117. Crystal data, moiety formula: C20H12N6, M = 336.36, monoclinic, a = 7.4315(3) Å, b = 15.4721(7) Å, c = 13.5859(6) Å, V = 1561.55(12) Å3, α = γ = 90.0°, β = 91.551(2)°, space group: P121/c1, Z = 4, Dcalc = 1.431 g·cm–3, no. of reflection measured: 14,333, unique: 2641, θmax = 66.49°, R1 = 0.0441 (CCDC 2070157).[43]

9-(4-Aminophenyl)-3-bromopyrido[1′,2′:2,3][1,2,4]triazino[5,6-b]indole-10-carbonitrile (5p)

Recrystallized from the EtOH/DMF mixture (1:4), as deep-orange crystals, yield: 2.00 g (96%), mp above 300 °C; IR (KBr): ν/cm–1 3438, 3320 (NH2), 2230 (C≡N), 1639, 1589 (C=N); 1H NMR (600 MHz, TFA-d): δ 7.66 (d, J = 7.2 Hz, 1H, CH-7), 7.84 (d, J = 8.4 Hz, 2H, Ar–H), 8.02–8.09 (m, 4H, Ar–H), 8.59 (s, 1H, Ar–H), 9.38 (d, J = 7.2 Hz, 1H, CH-8), the deuterium from the TFA-d has been exchanged with the exchangeable protons of NH2 in our sample effectively deuterating them and making them invisible in the proton spectrum; 13C{1H} NMR (150 MHz, TFA-d): δ 110.80, 118.20, 118.97, 122.25, 123.83, 127.25, 130.56, 133.50, 134.79, 137.72, 143.30, 144.81, 146.08, 146.60, 148.33, 150.07, 160.70; MS (EI): m/z (%) 416 (M+ + 2, 100.00), 415 (M+ + 1, 37.89), 414 (M+, 95.83). HRMS (EI): m/z calcd for C20H11BrN6 (M+), 414.0219; found, 414.0223.

9-(4-Aminophenyl)-3-nitropyrido[1′,2′:2,3][1,2,4]triazino[5,6-b]indole-10-carbonitrile (5q)

Recrystallized from the EtOH/DMF mixture (1:4), as deep-orange crystals, yield: 1.75 g (93%), mp above 300 °C; IR (KBr): ν/cm–1 3432, 3358 (NH2), 2224 (C≡N), 1640, 1590 (C=N); 1H NMR (600 MHz, TFA-d): δ 7.91 (d, J = 7.2 Hz, 2H, Ar–H), 8.03 (d, J = 8.4 Hz, 1H, Ar–H), 8.11 (d, J = 7.2 Hz, 2H, Ar–H), 8.23 (d, J = 6.6 Hz, 1H, CH-7), 8.89 (d, J = 8.4 Hz, 1H, Ar–H), 9.39 (s, 1H, Ar–H), 9.53 (d, J = 6.6 Hz, 1H, CH-8) The deuterium from the TFA-d has been exchanged with the exchangeable protons of NH2 in our sample effectively deuterating them and making them invisible in the proton spectrum; 13C{1H} NMR (150 MHz, TFA-d): δ 111.53, 113.11, 118.62, 124.43, 125.25, 127.71, 133.99, 135.06, 135.34, 137.92, 145.45, 147.00, 148.06, 150.52, 150.84, 152.24, 161.79; MS (EI): m/z (%) 382 (M+ + 1, 27.08), 381 (M+, 100.00). HRMS (EI): m/z calcd for C20H11N7O2 (M+), 381.1095; found, 381.1098.

9-Methylpyrido[1′,2′:2,3][1,2,4]triazino[5,6-b]indole-10-carbonitrile (5r)

Recrystallized from the EtOH/DMF mixture (1:4), as deep-orange crystals, yield: 1.15 g (90%), mp above 300 °C; IR (KBr): ν/cm–1 2226 (C≡N), 1643, 1595 (C=N); 1H NMR (600 MHz, DMSO-d6): δ 2.74 (s, 3H, CH), 7.39 (t, J = 7.8 Hz, 1H, Ar–H), 7.73–7.79 (m, 2H, Ar–H), 7.94 (d, J = 7.2 Hz, 1H, CH-7), 8.24 (d, J = 7.8 Hz, 1H, Ar–H), 9.11 (d, J = 7.2 Hz, 1H, CH-8); 13C{1H} NMR (150 MHz, DMSO-d6): δ 20.98 (CH3), 107.21, 114.12, 116.03, 118.64, 119.33, 121.80, 123.60, 134.47, 138.40, 140.54, 145.35, 147.63, 150.46, 156.04; MS (EI): m/z (%) 260 (M+ + 1, 21.36), 259 (M+, 100.00). HRMS (EI): m/z calcd for C15H9N5 (M+), 259.0852; found, 259.0852.
  25 in total

1.  Synthesis and antituberculosis activity of 5-methyl/trifluoromethoxy-1H-indole-2,3-dione 3-thiosemicarbazone derivatives.

Authors:  Ozlen Güzel; Nilgün Karali; Aydin Salman
Journal:  Bioorg Med Chem       Date:  2008-08-27       Impact factor: 3.641

Review 2.  Marine natural products.

Authors:  John W Blunt; Brent R Copp; Robert A Keyzers; Murray H G Munro; Michèle R Prinsep
Journal:  Nat Prod Rep       Date:  2017-03-17       Impact factor: 13.423

3.  A new vinyl selenone-based domino approach to spirocyclopropyl oxindoles endowed with anti-HIV RT activity.

Authors:  M Palomba; L Rossi; L Sancineto; E Tramontano; A Corona; L Bagnoli; C Santi; C Pannecouque; O Tabarrini; F Marini
Journal:  Org Biomol Chem       Date:  2016-02-14       Impact factor: 3.876

Review 4.  Modern advances in heterocyclic chemistry in drug discovery.

Authors:  Alexandria P Taylor; Ralph P Robinson; Yvette M Fobian; David C Blakemore; Lyn H Jones; Olugbeminiyi Fadeyi
Journal:  Org Biomol Chem       Date:  2016-07-12       Impact factor: 3.876

5.  Synthesis and anticancer activity of 2,4-disubstituted furo[3,2-b]indole derivatives.

Authors:  Shi-Hong Zhuang; Yi-Chien Lin; Li-Chen Chou; Mei-Hua Hsu; Hui-Yi Lin; Chi-Hung Huang; Jin-Cherng Lien; Sheng-Chu Kuo; Li-Jiau Huang
Journal:  Eur J Med Chem       Date:  2013-06-18       Impact factor: 6.514

Review 6.  A comprehensive review on xanthone derivatives as α-glucosidase inhibitors.

Authors:  Clementina M M Santos; Marisa Freitas; Eduarda Fernandes
Journal:  Eur J Med Chem       Date:  2018-08-07       Impact factor: 6.514

7.  Indium tri(isopropoxide)-catalyzed selective Meerwein-Ponndorf-Verley reduction of aliphatic and aromatic aldehydes.

Authors:  Jaeyoung Lee; Taekyu Ryu; Sangjune Park; Phil Ho Lee
Journal:  J Org Chem       Date:  2012-05-09       Impact factor: 4.354

8.  SYNTHESIS, CHARACTERIZATION AND BIOLOGICAL EVALUATION OF NEW FUSED TRIAZINE DERIVATIVES BASED ON 6-METHYL-3-THIOXO-1,2,4-TRIAZIN-5-ONE.

Authors:  Amira S Abd El-All; Ashraf S Hassan; Souad A Osman; Hisham Abdallah A Yosef; Wafaa H Abdel-Hady; Maher A El-Hashash; Saad R Atta-Allah; Mamdouh Moawad Ali; Ahmed A El Rashedy
Journal:  Acta Pol Pharm       Date:  2016 Jan-Feb       Impact factor: 0.330

Review 9.  Indole alkaloid marine natural products: an established source of cancer drug leads with considerable promise for the control of parasitic, neurological and other diseases.

Authors:  Waseem Gul; Mark T Hamann
Journal:  Life Sci       Date:  2005-10-19       Impact factor: 5.037

10.  Synthetic Strategy for Pyrazolo[1,5-a]pyridine and Pyrido[1,2-b]indazole Derivatives through AcOH and O2-Promoted Cross-dehydrogenative Coupling Reactions between 1,3-Dicarbonyl Compounds and N-Amino-2-iminopyridines.

Authors:  Haider Behbehani; Hamada Mohamed Ibrahim
Journal:  ACS Omega       Date:  2019-09-04
View more
  2 in total

Review 1.  Functionalized Triazines and Tetrazines: Synthesis and Applications.

Authors:  Joydip Mondal; Akella Sivaramakrishna
Journal:  Top Curr Chem (Cham)       Date:  2022-06-23

2.  High-Pressure Metal-Free Catalyzed One-Pot Two-Component Synthetic Approach for New 5-Arylazopyrazolo[3,4-b]Pyridine Derivatives.

Authors:  AbdElAziz A Nayl; Hamada Mohamed Ibrahim; Kamal M Dawood; Wael A A Arafa; Ahmed I Abd-Elhamid; Ismail M Ahmed; Mohamed A Abdelgawad; Hazim M Ali; Ibrahim Hotan Alsohaimi; Ashraf A Aly; Stefan Bräse; Asmaa Kamal Mourad
Journal:  Molecules       Date:  2022-09-27       Impact factor: 4.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.